PaulACullisMD

Neurology • Roseville, MI

Movement Disorder, Vascular Neurology

Chief of Neurology, Ascension Michigan

Join to view full profile

Dr. Cullis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cullis' full profile

Already have an account?

Office
25100 Kelly Rd
Roseville, MI 48066
Phone+1 586-771-7440

Fax+1 586-771-9966

Education & Training

Detroit Medical Center/Wayne State UniversityResidency, Neurology, 1980 - 1984
Birmingham University Medical SchoolClass of 1979
Detroit Medical Center/Wayne State UniversityFellowship, Vascular Neurology

Certifications & Licensure

MI State Medical License 1981 - 2027
IL State Medical License 2022 - 2026
FL State Medical License 1992 - 2025
WI State Medical License 2021 - 2025
AL State Medical License 2023 - 2023
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Publications & Presentations

PubMed

37 citations
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alt...
Steven J Warach, Anna Ranta, Joosup Kim, Shlee S Song, Adam Wallace
JAMA Neurology. 2023-07-01
25 citations
Cervical dystonia severity scale reliability study.
Christopher F. O'Brien, Allison Brashear, Paul A. Cullis, Daniel D. Truong, Eric Molho
Movement Disorders. 2001-11-01
16 citations
Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.
Paul A. Cullis, C. F. O'brien, Daniel D. Truong, M. Koller, T. P. Villegas
Advances in Neurology. 1998-01-01

Press Mentions

Newer Generation, Clot-Busting Stroke Medication Cuts the Risk of Serious Bleeding in HalfFebruary 3rd, 2022
Stroke Risk Plummets with Healthy LifestyleAugust 11th, 2008